Corporate GovernanceApr 30, 2026, 11:53 AM
EVO Nominates Dr. Hofmann to Board; Shareholder Agreement with MAK Capital
AI Summary
Evotec SE announced the nomination of Dr. Wolfgang Hofmann for election as an independent member of its Supervisory Board at the upcoming Annual General Meeting (AGM) on June 11, 2026. The AGM agenda also includes the previously announced nomination of Dieter Weinand as Chairman and a proposal to increase the Supervisory Board from six to seven members. Additionally, Evotec has entered into a cooperation agreement with key shareholder MAK Capital Fund LP, following constructive discussions, which includes customary voting and cooperation commitments.
Key Highlights
- Nomination of Dr. Wolfgang Hofmann as independent Supervisory Board member.
- Annual General Meeting (AGM) on June 11, 2026, to vote on Dr. Hofmann's appointment.
- AGM to also vote on previously announced nomination of Dieter Weinand as Chairman.
- Proposal to increase Supervisory Board size from six to seven members for AGM vote.
- Evotec entered into a cooperation agreement with key shareholder MAK Capital Fund LP.
- Agreement includes customary voting and cooperation commitments from MAK Capital.